Quotes delayed at least 15 minutes. Market data provided by Factset.Dow Jones Indexes Terms & Conditions. S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Mutual Fund and ETF data provided by Morningstar, Inc. Powered and implemented by FactSet Digital Solutions. Legal Statement.
|Mkt Cap||5.75 B|
|Next Earnings Date||n/a|
|52 Wk High||196.00|
|52 Wk Low||140.56|
GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its lead cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.